Joined Today: 1

MCET MultiCell Technologies, Stock Message Board

All Messages

MCET Message Board Home | Join The MCET Group |

#52: MCET News MultiCell Technologies Posts Journal Article on Research Leading to Company's Recent Patent Application on Novel Cancer Treatment
Stock News Bot	November 1, 2006 01:32:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#51: MCET News MultiCell Technologies Releases Transcript of Recent Investor Conference Call Discussing Recent Growth Initiatives and Growth of IP Portfolio
Stock News Bot	October 31, 2006 08:23:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#50: MCET News MultiCell Technologies Recaps New Investor Conference Call Discussing Recent Drug Development Initiatives and Strengthened IP Portfolio
Stock News Bot	October 26, 2006 08:43:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#49: MCET News WebAlert: MultiCell Technologies Investor Conference Call Starts Today at 12 Noon ET
Stock News Bot	October 25, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#48: MCET News MultiCell Establishes Clinical Development Team to Lead UK Phase IIb Human Clinical Trials for MCT-125 for the Treatment of Fatigue in MS Patients
Stock News Bot	October 24, 2006 01:04:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), a developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and... view message ignore post recommend post

#47: MCET News MultiCell CEO to Discuss First-in-Class Drug Candidates and IP Expansion in Online Interview with MN1.com Investment Broadcaster
Stock News Bot	October 24, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#46: MCET News MultiCell Technologies to Host Investor Conference Call to Discuss Progress in Development Programs and Growth of IP Portfolio
Stock News Bot	October 23, 2006 01:34:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB: MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#45: MCET News MultiCell Technologies CEO to be Featured Presenter at BIO InvestorForum 2006 Biotechnology Conference
Stock News Bot	October 17, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#44: MCET News MultiCell CEO Spotlights Breakthrough Immune-Modulation Technology in Online Interview with SmallCapInsights.com Investment Newsletter
Stock News Bot	October 16, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow’s smallcap breakthroughs, has announced the online release of... view message ignore post recommend post

#43: MCET News SmallCapInsights.com Investment Newsletter Provides Extended Coverage of MultiCell's Expanding Platform Technology Portfolio
Stock News Bot	October 13, 2006 01:14:00 PM
SAN DIEGO--(BUSINESS WIRE)--SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow’s smallcap breakthroughs, has announced a new installment of... view message ignore post recommend post

#42: MCET News MultiCell Technologies Announces Milestone Patent Issued by European Patent Office on Treatments for Autoimmune Diseases
Stock News Bot	October 12, 2006 01:03:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#41: MCET News WebAlert: MultiCell Technologies to Release CEO Interview to Discuss Progress in Business and Drug Development Programs
Stock News Bot	October 11, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on modulation of the immune system, will release an audio interview with... view message ignore post recommend post

#40: MCET News MultiCell Outlines Portfolio of Next-Generation Immune Modulation Therapeutics Technology in Updated Investor Fact Sheet
Stock News Bot	October 11, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#39: MCET News MultiCell Announces Intellectual Property Portfolio of First-in-Class Technologies Crosses Threshold of 50 Issued or Pending Patents
Stock News Bot	October 6, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB: MCET), a biopharmaceutical company developing first-in-class drugs based on advanced immune system modulation and... view message ignore post recommend post

#38: MCET News MultiCell and Fusion Capital Amend and Restate Common Stock Purchase Agreement to Provide for $8 Million of Equity Funding
Stock News Bot	October 5, 2006 03:22:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

Group Home | Login if you want to post a message